ArticleScientific reports2026
Hematological and immune cell changes in complete blood count before and after hemodialysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chronic kidney disease has a major impact on the quality of life and mortality, and affects nearly 10% of the global population, with 4.8% prevalence in Saudi Arabia, and the rates increase sharply with age. Despite advances in hemodialysis (HD) technology, several studies have demonstrated that it exposes patients to immune dysregulation, increasing vulnerability to infections and inflammation-related problems. This study aims to examine Complete Blood Count (CBC) alterations associated with HD, offering insight into hematological stability and immune cell dynamics that could refine patient monitoring and improve clinical outcomes. A total of 107 patients were included in this study, of whom 55.1% were male and 44.9% were female. According to our results, HD changes the dynamics of immune cells. Males showed higher percentages of neutrophils, while females showed higher counts of lymphocytes and monocytes before HD, indicating sex-based immune differences. Additionally, HD was linked to decreases in WBCs and RBC parameters, emphasizing immunological suppression and anemia as major clinical challenges. These results highlight the significance of taking age, sex, and comorbidities into account when interpreting CBC changes in HD patients. They also highlight the need for biomarkers and that accurately evaluate the immune and hematological health of this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.